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University of Pittsburgh, 2005 
 
 
         The innate immune response is the first barrier against external stimuli arising from 
disease-causing pathogens. The primary membrane associated Toll-Like receptors (TLRs) play 
an important role in the innate immune response by recognizing pathogen-associated molecular 
patterns (PAMPs). Recently nucleotide-binding oligomerization domain (NOD) proteins have 
been shown to serve as intracellular receptors that are also involved in the innate immune 
response. Caveolae are small plasma membrane invaginations that exist in a wide range of cell 
types. The overall goals of this proposal are to examine the molecular determinants of the 
interaction of the intracellular pathway (NOD2) with plasma membrane (TLR2) mediated events 
in the response of epithelial cells to bacterial pathogens and to identify the role of caveolae in the 
signaling events that may underlie this association. Revealing the mechanisms of interaction 
between NOD2 and pathogens has significant importance to control or prevent Crohn's disease 
and benefits the public health issues. Accordingly, the specific aims are:  
Aim 1: To reveal the molecular mechanism for the interaction between NOD2 and MDP. 
We hypothesize that a cognitive sequence in the LRR of NOD2 recognizes MDP and the 
cognitive sequence accounts for the interaction of PGN from Gram-positive microorganism in 
polarized epithelial cells. 
Aim 2:  to determine the requisite role of NOD2/MDP pathway in response to Gram-
positive infection.  We hypothesize that constitutive levels of NOD2 are low in polarized 
epithelial cells. Gram-positive infection results in synthesis of TNFα that increases NOD2 
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expression and TNFα in an autocrine fashion and enables the cells to participate in host defense 
via synthesis of IL-8.  
Aim 3:  to identify an interaction between NOD2 and TLR2 pathways in mediating 
Gram-positive bacterium Staphylococcus aureus activation (IL-8 synthesis) in polarized MDCK 
cells. IL-8 synthesis in response to gram-positive infection will be contrasted in wildtype MDCK 
cells vs. cells in which NOD2, TLR2 or both have been silenced by siRNA. We also hypothesize 
that cross talk between NOD2 and TLR2 pathways occurs at a MAP kinase step and accordingly, 
experiments will be repeated in the presence of pharmacological (or genetic, e.g. dominant 
negative) inihibitors of p38, JNK and MAPK. 
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1. Background and Significance 
               
Crohn's disease (CD) is an inflammatory disorder that is characterized by transmural 
inflammation, epithelial ulceration, fissure formation, and stenosis of segments of the entire 
gastrointestinal tract[1, 2]. There is a significant environmental influence on the development of 
Crohn's disease, but a genetic element also plays a role; at least five separate genetic loci have 
been linked to Crohn's disease. Nucleotide-binding oligomerization domain protein 
NOD2(Card15), the first susceptibility gene for CD, has also been found to be an intracellular 
recognition receptor of the muramyl dipeptide component of peptidoglycan (PGN)[3].  However, 
it’s not yet known in detail how the mutation of NOD2 is connected to the pathogenesis of CD. 
Since the NOD2 gene product is thought to be an intracellular receptor for bacterial wall 
products, microbial factors have been the recent focus of attention. Through a better 
understanding of the mechanisms of interaction between NOD2 and pathogens, we may uncover 
novel means to utilize the anti-bacterial function of NOD2 to develop strategies to control or 
prevent CD.  
1.1. Innate immunity: 
 
Organisms depend on innate and adaptive immune responses to defend themselves 
against invaded pathogens. Innate immunity relies on specific pattern-recognition receptors 
(PRRs) to recognize the pathogen-associated molecular patterns (PAMPs) thus creating the 
immune system first line of defense. It is well known that Toll-like receptors (TLRs) play a key 
role in mediating responsiveness to bacteria and bacterial products in cells of the myeloid 
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 lineage. TLRs set the tone and pace of the inflammatory response that follows initial contact with 
pathogens within different periods of time. To date, more than 10 TLRs have been identified as 
well as their potential ligands. For example, TLR4 recognizes lipopolysaccharide (LPS), TLR3 
recognizes double-stranded RNA, and TLR9 recognizes bacterial DNA. All TLRs are 
transmembrane molecules and express on either typical immune cells such as macrophages, 
neutrophils, dendritic cells, or epithelial cells. The stimulation of TLRs by their agonists requires 
the recruitment of specific adaptor molecule including MyD88. An overview of TLR signaling 
pathways is shown in figure 1[4]. 
 
 
Figure 1:  Ligands recognized by Toll-like receptor (TLR) family. 
 
Among TLRs, the study of function of TLR2 has been addressed in relatively more 
detail. Ligand recognition and signaling of TLR2 is a little more complicated than other TLRs. 
The characters and function of TLR2 have been noted as: a) TLR2 is a cell-activating receptor 
for gram-positive bacteria (For example, Staphylococcus and Streptococcus), mycobacteria, and 
for the cell wall components (lipoteichoic acid lipopeptides, lipoproteins et al); b) TLR2 mainly 
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 recognizes its ligands as a heterodimer with either TLR1 or TLR6 (some other TLRs or non-TLR 
molecules will also form the heterodimerization with TLR2) [5]; c) CD14 is a major co-receptor 
required for signaling induced by TLR2 ligands. For example, upon binding to ligand, CD14 can 
efficiently transfer as well as enhance the recognition of TLR2 to pathogen components [6]; d) 
Like other TLRs, the TLR2 signaling is significant, because it induces antigen presenting cell 
activation, pro-inflammatory cytokine production, and increases expression of co-stimulatory 
ligand expression. Alteration or lack of TLR2 function in vivo may lead to decreased protection 
response required by TLR2. Evidence strongly supports the critical role of TLR2 in the induction 
of innate immune responses and improved acquired immunity.  
TLRs are mainly expressed at the surface of innate immune-responsive cells and detect 
microbes in the extracellular compartment. In recent reports, it was found that two nucleotide-
binding oligomerization domain (NOD) family member proteins, Nod1 (Card4) and NOD2 
(Card15), can detect intracellular pathogens that avoid TLR-mediated detection[7]. The 
responsiveness conferred by NODs is MyD88-independent. Since both Nod1 and NOD2 are 
cytoplasm proteins, these findings highlight that Nod1 and NOD2 are intracellular PRRs for 
peptidoglycan.   
1.2. NOD2 gene and protein scheme: 
NOD proteins belong to a growing family of cytosolic factors[8]. NOD proteins have 
three functional domains— an amino-terminal effector-binding domain (EBD) (which mediates 
binding to effector molecules, controlling the downstream events), a centrally located NOD 
(Which mediates self-oligomerization for downstream effector molecules activation), and 
carboxy-terminal leucine-rich repeats (LRRs) (Fig.2.)[1]. The caspase-recruitment domain 
(CARD) and the pyrin domain (PYD) are two EBDs. The LRRs are important for ligand 
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 recognition. Mutagenesis in the LRRs abolishes the NF-κB activation of NOD2 upon MDP 
stimulation. Although functional properties have been demonstrated, limited data has been 
published to address the question of weather or not NOD2 will interact with MDP[1] directly or 
indirectly. In this proposal, a series of studies will be conducted to examine the mechanism 
of the interaction of NOD2 with MDP. We will test the influence of LRR domain mutation 
on the interaction of NOD2 with MDP in an in vitro assay system as well as in a cell culture 
system. 
 
Figure 2:  The NOD2/CARD15 gene contains 12 exons. The encoded protein contains two caspase 
recruitment domains (CARDs), a nucleotide binding domain (NBD) and 10 leucine-rich repeats (LRRs)[1]. 
 
1.3. NOD2 ligand specificity and signal transduction: 
In contrast to Nod1 which is broadly expressed in tissues[9], the expression of NOD2 
seems to be more restricted to monocytes. Recent reports showed that NOD2 was also expressed 
in granulocytes, dendritic cells, and to a lesser extent in T lymphocytes[10]. In inflammatory 
conditions, NOD2 expression levels are significantly up-regulated in myelomonocytic and 
epithelial cells upon stimulation with TNFα and bacterial degradation products. Results from 
Aldhous et al.[11] showed that the expression of NOD2 in the Paneth cell could be critical in the 
pathogenesis of Crohn’s disease.  
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 Inohara et al. and Bertin et al.[9, 12] first reported that Nod1 could activate the NF- B 
pathway when overexpressed in the human embryonic kidney cell-line 293T(HEK 293). Very 
recently, Girardin and Chamaillard et al. [13-15] identified NOD1 as an intracellular sensor for 
specific peptidoglycan (PGN) muropeptides. By excluding the possibility of contamination of 
bacterial cell-wall components, further results confirmed that NOD2 is a PRR for PGN[15]. So 
besides the extracellular guarding system of TLRs, NOD proteins have been discovered for 
intracellular sensing of bacteria in mammals. NOD2 recognizes both Gram-negative and Gram-
positive bacteria through the N-acetylmuramyl dipeptide (MDP) component in their PGN.  
Signaling through NOD2 is mediated through the kinase RICK, which interacts with 
NOD2 through homophilic CARD-CARD interactions. Experiments on mouse embryo 
fibroblasts lacking in RICK showed that Nod1 and NOD2 do not activate NF- B[16], but as long 
as exogenous RICK is added in, NF- B activity can be restored. An intermediate region exists 
between the CARD and the kinase domain of RICK that interacts with IKK complex regulatory 
subunit IKK [9, 12], thus linking Nod1 and presumably NOD2 to the IKK. In addition to NF-
B, Nod1 has been reported to activate c-JUN N-terminal kinase (JNK) in response to bacteria but 
the concrete mechanism is unclear. It is also unclear how TLR2 and NOD2 collaborate with each 
other. Both TLR2 and NOD2 are important PRRs for Gram-positive bacterial and are involved in 
the recognition of same bacterial product, either outside or inside cells. In this proposal we will 
try to find out the detail overlap, or redundant functional relationship between NOD2 and 
TLR2. 
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 1.4. MDP: 
Peptidoglycan (PGN) and lipopolysaccharide (LPS) are the two most commonly studied 
components of Gram-positive and Gram-negative bacterial cell walls. Muramyldipeptide (MDP) 
is the minimum structural moiety of bacterial peptidoglycan (PGN) for adjuvant and related 
activities[17]. MDP is ubiquitously distributed in bacterial cell walls and expresses especially 
high levels in Gram-positive bacteria. The receptor and signaling system for MDP were shown to 
be different from that for PGN, suggesting the presence of a recognition system other than 
CD14/TLR. MDP activated human monocytic cells in a CD14-, TLR2- and TLR4-independent 
manner to increase MyD88 expression[17]. MDP not only synergizes with LPS but also acts 
similarly with PGN to induce the synthesis of TNF  in the human monocytic cell line Mono Mac 
6[18]. In quiescent epithelial cells, the expression of NOD2 is low or null, but the up-regulation 
of NOD2 is significant after TNFα stimulation. 
1.5. Caveolae localization and function:  
Caveolae have gained attention in recent years because of the discoveries that caveolae 
play a role in the cellular uptake and intracellular delivery of certain bacterial toxins, viruses, and 
bacteria[19-21]. Caveolae are rich in cholesterol, sphingolipids, caveolin-1 and are considered to 
be a subset of lipid rafts[22]. They are flask-shaped invaginations 50-100 nanometers in diameter 
and are highly ordered microdomains residing within the plasma membrane. The intracellular 
trafficking of bacteria via caveolae is the pathway different from the classical route of ligands 
internalized by clathrin-medited endocytosis. Caveolins are the major protein component of 
caveolae. The caveolin gene family has three members in vertebrates: caveolin-1, caveolin-2, 
and caveolin-3. Caveolins distribute predominantly at the plasma membrane but also in the 
Golgi, the endoplasmic reticulum, in vesicles, and at cytosolic locations. Caveolae are expressed 
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 ubiquitously in mammals and certain continuous endothelial and epithelial cells[23, 24]. The 
finding that silencing the expression of caveolin protein decreased the uptake of pathogen 
reagents confirmed the important role of caveolae in the vesicle docking and transport into the 
cell. The high concentration of signaling molecules (such as heterotrimeric G proteins, non-
receptor tyrosine kinases, et al.) determines the versatile functions of caveolae. Caveolins 
participate in many important cellular processes, including vesicular transport, cholesterol 
homeostasis, signal transduction, and tumor suppression. Recent documents states that caveolae 
constitute an alternative endocytic pathway to clathrin-coated pits and transport their select cargo 
for ultimate delivery to the Golgi[25]endoplasmic reticulum(ER)[26], or lysosome [27]. 
Caveolae have participated in Gram-negative bacteria endocytosis. We predict a similar function 
of caveolae for internalization of Gram-positive bacteria. MDP is one known ligand for NOD2, 
but how epithelial cells take up MDP is poorly understood. The mechanisms by which Gram-
positive bacteria enter the cell, and by which MDP is recognized by NOD2 have not been 
addressed. We propose to examine the role of caveolae in the NOD2/MDP pathway.  
Although there have been years of intensive research devoted to Crohn disease (CD), the 
etiology of the disease is still unknown. In 2001, NOD2, the first susceptibility gene for CD was 
discovered. Although mutational assays and epidemiological data have shown that patients with 
mutations on the NOD2 gene are susceptible to CD disease, it remains difficult to establish the 
impact of these discoveries on the clinical management of patients. Revealing the molecular 
mechanism of Nod2 function may provide a better understanding the pathogenesis of Crohn's 
disease [28]. 
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 2. Preliminary Studies: 
2.1. To reveal the molecular mechanism for the interaction between NOD2 and MDP. 
2.1.1. NOD2 is a general sensor of bacterial PGN but not of LPS: 
 
Commercial and endotoxin-free purified bacterial PGN triggered NF- B in NOD2-
transfected cells instead of LPS. This kind of PGN-induced activation was NOD2-dose 
dependent and required the LRR domain. In figure 3, HEK293 cells (transfected with or without 
NOD2) were treated with different PAMPs. The results suggested that NOD2 confers 
responsiveness to PGN, but not to LPS. When NOD2 was mutated at the LRR domain, PGN 
could not trigger NF- B in NOD2-transfected cells. (Fig.3)[29, 30]. Study also revealed that 
Nod2 was a general sensor of peptidoglycan through MDP detection[15]. 
 
 
Figure 3:  Differential sensing of cytosolic PAMP by NOD2. 
 
The delivery of MDP to the cytosol varies in different pathogens and cells. Invasive 
pathogens penetrate the cells freely. Phagocytic cells containing intracellular hydrolases can 
digest bacterial peptidoglycan, resulting in the release of muropeptides. Lysozyme presenting in 
the serum might also process extracellular peptidoglycan to release muropeptides. Some 
intracellular bacteria like Listeria could produce muropeptides during replication. Nonetheless, 
it’s still unclear how muropeptides enter the cytosol from extracellular compartments or from the 
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 phagosome across phagosome membranes. Whether MDP directly binds to NOD2 or interacts 
with this protein via other intracellular factors has to be determined. The mechanism concerning 
how NOD2 recognizes MDP is waiting for further investigation. In this proposal we will try to 
investigate the interaction between NOD2 with MDP as well as the role of caveolae in the 
MDP internalization and NOD2/MDP interaction. 
 
2.1.2. Caveolae involve in Gram-negative bacterial invasion: 
 
It’s well known that Nod2 is a cytosolic protein and recognizes the minimal structure of 
bacterial cell wall component peptidoglycan ── MDP. Studies have shown that degradation of 
peptidoglycan into MDP may be caused by enzymes like ceradase. It’s not known how the 
bacteria and their components come inside the cell and how the cytosolic protein NOD2 
recognizes the MDP. Clathrin-coated vesicles are the general pathway for bacterial endocytosis. 
However, pathogens may skip to the alternative pathway such as caveolae to enter into the cells 
to avoid the entry of lysosome. Caveolae have also been found in immune cells like macrophage, 
monocyte, or dendritic cells[31], which suggesting that caveolae may participate in the cell 
surveillance for pathogen invasion.  
Indeed, caveolae have been found as portals of entry for microbes, at least for Gram-
negative bacterial invasion. Various concentrations of either filipin or cyclodextrin were 
incubated with confluent monolayers of Human Brain Microvascular Endothelial Cells (HBMEC) 
before performing the E. coli invasion assays. Caveolae disrupters Filipin as well as cyclodextrin 
were found to be effective in blocking the invasion of OmpA+ E. coli (E44) in a dose-dependent 
manner (Figure 4) [32]. In contrast, the binding activity was not influenced. Caveolae may also 
play a role in the entry of bacteria into other nonphagocytic cells like epithelial cells[33]. Since 
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 caveolae help Gram-negative bacterial invasion, we predict that caveolae also participate in the 
Gram-positive bacterial internalization. In this study we will examine if caveolae is involved in 
1) the binding of MDP to NOD2, and 2) the MDP-induced IL-8 synthesis.  
 
Figure 4:  Inhibition of E. coli invasion of HBMEC by filipin and cyclodextrin in a dose-response manner. 
 
2.1.3. NOD2 but not NOD1 could recognize Gram-positive internalized bacterial 
Streptococcus pneumoniae: 
 
Nod1 and Nod2 are both intracellular receptors for pathogen recognition. However, Nod1 
can not recognize Gram-positive bacteria while Nod2 can act on both Gram-positive and 
negative bacteria. The broad recognition properties of Nod2 enable it to be important for Gram-
positive bacterial detection. As shown in Figure 5, HEK293 cells were transiently transfected 
with or without Nod1/Nod2 expression plasmids, an NF- B-dependent luciferase reporter, and an 
RSV -galactosidase plasmid. Nod2 conferred a dose-dependent responsiveness to inactivated 
pneumococci and MDP [34], but Nod1 does not. Obviously, the result suggested that both as an 
intracellular receptor, NOD2 is more important for Gram-positive bacterial sensing.  
10 
  
Figure 5:  Nod2 mediates NF-κB activation by the inactivated pneumococci when intracellularly challenged. 
 
2.2. To determine the requisite role of NOD2/MDP pathway in response to Gram-
positive infection. 
2.2.1. Nod2 gene could be regulated by TNFα in intestinal epithelial cells: 
 
Although Nod2 is expressed at low levels in quiescent stage, NOD2 mRNA would be 
increased greatly in a monocyte cell line in response to lipopolysaccharide, lipoteichoic acid, 
interferon-γ and TNFα. The expression of NOD2 in cloned at epithelial cells is more sensitive to 
TNF  stimulation[10]. In this experiment, cells were stimulated by TNF  for 24 h and evaluated 
for the elevation of NOD2 mRNA. The levels of NOD2 mRNA in the SUM159 and MCF-7 were 
increased about 1.5- and 6-fold respectively (Fig.6, A and B). Up-regulation of NOD2 mRNA 
levels was more prominent (23-fold) in the colon epithelial cell line FHC (Fig. 6B) [10]. The fact 
that the NOD2 gene can be regulated by proinflammatory cytokines suggests an important role 
for NOD2 in innate immunity. Up-regulation of NOD2 genes as a consequence of 
proinflammatory cytokines stimulation could be accomplished via NF-κB activation: 
 
11 
  
Figure 6:  Induction of NOD2 mRNA in epithelial cells treated with TNF . 
 
The increased expression of NOD2 in intestinal epithelial cells has been confirmed, what 
not been known to us is that how the NOD2 expression been regulated by cytokines. Improper 
regulation of NOD2 expression will either lead to inactive reaction for pathogen invasion or 
induce overwhelming inflammatory response.  
 
2.3. To identify an interaction between NOD2 and TLR2 pathways in mediating Gram-
positive bacterium Staphylococcus aureus activation (IL-8 synthesis) in polarized MDCK 
cells 
2.3.1. Role of TLR2 in the innate immunity: 
 
The function role of TLR2 for recognizing Gram-positive bacteria has been described in 
quantities of studies. After transfection with TLR1 or TLR2 plasmids, HEK293 cells were 
treated with Gram-positive bacteria (Micrococci) and Peptidoglycan (PGN) to observe the IL-8 
level as reflected by CAT activity. Micrococci and PGN induced transcription of IL-8 in 
HEK293 cells expressing Toll-like receptor 2 (TLR2) and CD14 but not in those expressing 
TLR1 or TLR4 (Figure 7)[35]. It has also been shown that S. aureus cell wall-mediated TNF  
production was fully TLR2 dependent [36]. Study on various doses of bacterial challenge on 
12 
 HEK293T cell showed that TLR2-dependent NF-κB activation is bacterial concentration 
dependent, rather than PGN content dependent (Figure 8) [37].  
 
 
Figure 7:  Micrococci (Micro) and sPGN induce transcription of IL-8 in HEK293 cells expressing TLR2, and 
this induction is NF- B dependent. 
 
Figure 8:  Dose-dependent HEK293T cells stimulation with tenfold increasing amounts of HK S. aureus and 
S. pneumoniae. 
 
The critical role for TLR2 in host defense against Gram-positive bacteria was strongly 
supported by in vivo TLR2 gene disruption experiment. In these studies, TLR2-/- mice were 
significantly more susceptible to lethal infection after a high-dose challenge (1 x 107 CFU S. 
aureus). As shown in Figure 9, all wild-type mice survived for 8 days after S. aureus inoculation 
and 60% survived on day 14. In contrast, about 80% of TLR2-deficient mice succumbed to S. 
aureus and died within 8 days, and only 10% survived on day 14 [38].   
13 
  
Figure 9:  Survival of TLR2-deficient mice (n = 10, ) and wild-type mice (n = 10, ) after i.v. infection of 1 x 
107 CFU of S. aureus. p < 0.03 in log rank test. 
 
2.3.2. Potential relationship between NOD2 and TLR2: 
 
The potential cross talk between NOD2 and TLR2 has been implicated in several 
studies[3, 39, 40]. It is conceivable that the TLR and NOD pathways cooperate to enhance the 
immunological response. Experiments in Nod2 (-/-) mice showed that intact NOD2 signaling 
inhibited TLR-2 driven activation of NF-κB [40]. As shown in Figure 10, total splenocytes 
obtained from wild-type and NOD2-/- mice were stimulated with pure synthetic TLR2 ligands 
(Pam3Cys or Pam3CSK4) and MDP, Culture supernatants were collected and analyzed for 
cytokine production by ELISA. Results showed that TH1 cytokines (IL-12, IFN-  and IL-18) 
secretion increased in NOD2 -/- mice. The fact that NOD2 stimulation initiates both pro-
inflammatory and anti-biotic response suggests the complicated role of NOD2 in the innate 
immunity. 
 
14 
  
Figure 10:  Splenocytes from NOD2 -/- mice show enhanced TH1 cytokines production after stimulation with 
MDP together with the pure (synthetic) TLR2 agonists Pam3Cys and Pam3CSK4. 
 
Both TLR2 and NOD2 are used for sensing Gram-positive bacterial, TLR2 acts as an 
extracellular receptor while NOD2 acts as an intracellular sensor. In this study, we will examine 
if there is any cross talk between TLR2 and NOD2 in bacteria-induced IL-8 synthesis in 
epithelial cells. Particularly, we would like to examine MAP kinase signal pathway to see 
any relationships between TLR2 and NOD2 on Gram-positive bacterial stimulation. 
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 3. Research Design and Methods: 
 In this part, experimental design and specific protocols will be listed first and then 
followed by necessary experimental techniques.  
3.1. Experimental design and specific protocols 
3.1.1. To reveal the molecular mechanism for the interaction between NOD2 and MDP. 
3.1.1.1. Objective: 
 
To test the hypothesis that a cognitive sequence recognizes MDP in the LRR of NOD2 
and accounts for the interaction with PGN from Gram-positive microorganism in polarized 
epithelial cells. Particularly, we will try to examine 1) How mutagenesis of the LRR domain of 
NOD2 will affect the interaction of NOD2 with MDP, and 2) How caveolae are involved in the 
internalization of MDP in the cells and the subsequent interaction with NOD2. To address the 
first question, we will mutate the various sequences within both the N-terminal and C-terminal of 
the LRR domain of NOD2, and then we will examine whether this modification will affect the 
interaction of MDP with NOD2 in an in vitro assay as well as in intact cells.  
To figure out the role of caveolae in MDP internalization and its subsequent interaction 
with NOD2, we will first determine the subcellular co-localization of NOD2 and MDP with 
caveolae. To further investigate if biochemical disruption of caveolae by detergent will influence 
the MDP internalization, or its interaction with NOD2 and IL-8 synthesis as a consequence. We 
will use optical imaging to trace the co-localization of transfected GFP-caeoline-1 and Alexa 588 
labeled MDP via laser scanning confocal microscopy. We also want to find out whether 
disruption of caveolae with detergent will affect IL-8 systhesis.  
3.1.1.2. Protocol: 
 
To address the question of pathway selection by Gram-positive bacteria, we will 
investigate whether the bacteria are internalized via caveolae in MDCK cells. 
16 
 1) Mutagenesis:  
We will generate the mutagenesis of the various sequences within both the N-terminal 
and C-terminal of LRR domain of NOD2. The strategy to perform random mutagenesis of 
NOD2 has been described before [41, 42]. Each cassette containing the coding region of NOD2 
will be mutated using the GeneMorph PCR kit. Each primer will be designed to contain 
restriction sites so that each PCR product will be digested with appropriate restriction enzymes 
and inserted in-frame into the remainder of the coding region of NOD2. The NOD2 3020insC 
mutation that renders truncation of the NOD2 at position 1007 was determined using the allele-
specific multiplex PCR assay described by Ogura et al. Deletion and site-directed mutants as 
well as wide-type NOD2 will be cloned into pcDNA3 vector. Expression plasmids will be 
amplified and purified for in vitro binding assay. 
a) In vitro binding assay: The microplate will be pre-coated with Avidin. We will label 
wild type and mutated NOD2 with biotin and incubate with Avidin. Two hours later 
fluorescently labeled MDP will be added and incubated for another 2 hours before measurement 
of fluorescence intensity. 
b) Interaction of NOD2 with MDP in intact cells: Wild type and mutated NOD2 cDNA 
will be cloned into pcDNA3-HA. Expression plasmids will be transient transfected into MDCK 
cells. Twenty four hours post-transfection, 10ng/ml biotin labeled MDP will be transfected in the 
presence of calcium phosphate to allow their entry into the cells as reported[39, 43]. Proteins 
from cell lysate will be coimmunoprecipitated with an anti-HA antibody and subsequently 
detected with bioin-Avidin interaction to track the existence of MDP. For colocalization assay, 
we will construct various NOD2-EGFP fusion proteins, transfect express plasmids into MDCK 
cells and add rhodamine-labeled MDP. At different time points, we will fix cells and observe 
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 NOD2/MDP co-localization using laser scanning confocal microscopy to detect the binding of 
MDP with NOD2.  
2) Interaction of caveolae with NOD2/MDP: 
Construction of GFP-caveolin-1: GFP will be attached to the C-terminal end of caveolin-
1. HindIII restriction sites will be added to both 5' and 3' ends of the caveolin-1 cDNA by PCR 
using the Expand High Fidelity PCR system. The PCR product will be digested with HindIII and 
inserted into the HindIII site of the EGFP-N1 eukaryotic expression vector. The proper 
orientation and sequence of caveolin-1-GFP will be verified by sequencing. The polybrene 
method will be used to transfect MDCK cells with the caveolin-1-GFP construct. Transfected 
cells will be selected by growing in 0.8 mg/ml G418 for 14 days. Individual clones will be 
isolated and screened for expression of the caveolin-1-GFP by fluorescent microscopy. 
Methyl-b-cyclodextrin and filipin pretreatment: MDCK cells with be preincubated with 
different amounts of methyl-b-cyclodextrin (1, 2, 5, 10 mM) and filipin (1,5,10 and 20 mM) in 
25 mM Hepes buffered DMEM for 1 h at 37°C, wash thoroughly with Hepes-DMEM, and then 
incubate with 0.5 mg ml-1 Alexa 488 coupled with MDP for 15 min. Infection will be stopped 
by fixation with 1% formaldehyde. Or, we will do time- and concentration-dependent MDP 
uptake experiment under which caveolin will either over-expressed or be downregulated by 
siRNA. 
Immunofluorescence and confocal microscopy: MDCK cells expressing the GFP-
caveolin-1 construct will be grown on coverslips and pretreated with and without detergent. They 
will then be treated with Alexa Fluor 588 labeled MDP and incubated for 8 h. We will wash the 
cells five times in PBS and fix with 2% paraformaldehyde for 15 minutes at room temperature 
and continue incubation with 5% normal serum blocking solution for 20 minutes. Cells will then 
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 be immunostained to detect NOD2 by incubation with primary and secondary antibodies at room 
temperature for 1 h and for 45 min, respectively. Coverslips will be mounted using Fluoromount-
G and viewed with epifluorescence microscopy. For colocalization of NOD2 and caveolin, 
MDP, confocal microscopic analysis will be carried out using the TCS SP1 confocal imaging 
system. 
IL-8 assays: We will expose confluent monolayers of MDCK cells to the medium 
without serum for 24 hours then to Staphylococcus aureus for 60 minutes with and without 
pretreatment with Methyl-b-cyclodextrin or filipin for 30 minutes. Cells will be washed, 
sterilized with gentamicin (100 g/ml), and the supernatants harvested at the different time points 
for IL-8 ELISA assay.  
 
3.1.1.3. Expected Results, Problems, and Solutions: 
 
In this protocol, we try to figure out any potential role of caveolae in the interaction of 
NOD2 and MDP. Because almost all the cells share the same IL-8 promoter, the functional 
analysis indicated by IL-8 expression has the cell type significance. The expression pattern of 
fluorescently labeled NOD2 will be compared for the similarity in several different clones and 
different cell lines. Our results will show the recruitment migration of the NOD2 toward 
internalized MDP. Within the subcellular level, we will reveal if NOD2 will be expressed in the 
ER or Golgi complex and how and where the NOD2-MDP will be processed. We expect that 
fluorescent microscopy will reveal a diffuse cytoplasmic staining of NOD2 in untreated cells. 
Subsequent stimulation with MDP will induce rapid redistribution of NOD2 and perinuclear 
condensation after interval exposure. MDP will colocalize with intracellular NOD2 staining as 
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 well as the cellular distribution of Golgi marker C5 ceramide. We expect that the LRR will be 
critical for MDP binding. Alternatively, we will consider CARD region of NOD2. 
Based on the special functional role of caveolae in the internalization of pathogens and 
previous results, we expect that MDP/NOD2 will be relevant to caveolae. In the event that 
neither filipin nor caveolin-1 overexpression will inhibit the internalization and transportation of 
MDP in confluent MDCK cells, we would like to do the following things: use siRNA to 
specifically silence the expression of caveolin-1 or other caveolin isoforms caveolin-2 or 3. 
Considering the alternative pathway, which is named clathrin-dependent endocytosis, we may 
pick up other inhibitors such as chlorpromazine and potassium depletion to destroy clathrin and 
evaluate the possible pathway via clathrin. Others such as cholesterol-disruption agents, dynamin 
function inhibitors may be served in multiple studies with different cell strains to argue the 
critical role of caveolae.  
 
3.1.2. To determine the requisite role of the NOD2/MDP pathway in response to Gram-
positive infection. 
3.1.2.1. Objective: 
 
We hypothesize that constituitive levels of NOD2 are low in polarized epithlelial cells.  
Gram-positive infection results in the synthesis of TNFα that increases NOD2 expression in an 
atuocrine fashion and enables the cells to participate in host defense via synthesis of IL-8. We 
will measure IL-8 synthesis after Gram-positive infection in wild type MDCK cells and compare 
this response to cells in which TNFα or NOD2 is downregulated by siRNA. Complementation of 
the deleted genes with direct gene transfer will be used to confirm their critical roles.  
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 3.1.2.2. Protocol: 
  
The methods for the NOD2 and TNFα siRNA design will be used as follows: A double-
stranded oligonucleotide siRNA will be designed to contain a sequence derived from the NOD2 
open reading frame (ORF). For the target purpose, siRNA design will be focused on NOD2 ORF 
promoter region, both in forward and reverse orientation.  The TNFα siRNA sequence will be 
generated via a similar way. For the siRNA transfection, MDCK cells will be seeded at a density 
of 105/ml in 24-well plates. Graded concentrations of siRNAs for NOD2/ TNFα siRNA and a 
control siRNA will be transfected into cells using Oligofectamine according to the 
manufacturer’s instruction. 
Role of Nod2/MDP pathway in the direct TNF  stimulation: We will transfect MDCK 
cells with or without Nod1/Nod2 siRNA (different dose with different time points). Forty eight 
hours later, MDCK cells will be treated with TNF . To observe the functional consequences of 
Nod2, at the different time points, MDCK cell supernatant will be collected and the IL-8 level 
will be assayed.   
Role of Nod2/MDP pathway in the endogenous TNF  stimulation: MDCK cells will be 
treated with Gram-positive bacteria S. aureus. siRNA experiment will  be designed as follows: a) 
siRNA for NOD2; b) siRNA for TNFα; c) siRNA for both NOD2 and TNFα. At various time 
points, we will assay IL-8 level from the cell supernatant. The production of TNF  will be 
analyzed using an ELISA kit. We will blot total cell lysates with specific antibodies for NOD2 or 
TNFα.    
Reinstatement assay:  We will redirect the NOD2 or TNFα gene into the above cells 
already being treated with siRNA to see if the functional synthesis of IL-8 will be restored. 
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 Transfect NOD2/TNFα containing plasmids into the siRNA pretreated cells, and then we will 
stimulate them with S. aureus. Finally we will re-evaluate the synthesis of the IL-8 level.  
3.1.2.3. Expected Results, Problems, and Solutions: 
 
We predict that TNFα increases NOD2 mRNA in a manner that is dependent on dose and 
time. The NOD2/MDP pathway has an important role in proinflammatory stimulation (sensitive 
to siRNA to NOD2). The down-regulation effect of siRNA could be recovered after restoring the 
NOD2 and/or TNFα genes. To overcome the possibility that the siRNA fragment is not the 
critical one for the gene silencing, we will try to pick up multiple sites. Alternatively, we will co-
transfect multiple siRNA fragments in order to silence the functional sites of NOD2. These 
siRNA target sites could either be located at the LRR domain (interfere MDP recognition) or at 
the Card domain (disrupt NF-κB activation). To further confirm the hypothesis, in vivo 
experiments will be needed. Specifically, an animal model with conditional knockout NOD2 or 
TNFα genes will be used. Alternatively, considering the external sources of TNFα, we may add 
in the TNFα antibody to block the entry of exogenous TNFα to observe the autocrine effect. To 
exclude the possible role of the TLR2 effect, we may choose other cell types, or using HEK293 
cells (TLR2 exclusive). 
 
3.1.3. To identify an interaction between NOD2 and TLR2 pathways in mediating 
Gram-positive bacterium Staphylococcus aureus activation (IL-8 synthesis) in 
polarized MDCK cells. 
3.1.3.1. Objective: 
 
We will try to find out if there is any co-operation between TLR2 and NOD2 in the 
immune response against Gram-positive bacterial infection. We will also determine whether 
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 MAP kinase activation plays any role in the TLR2/NOD2 synergistic effect. To address this 
issue, we will silence the expression of either TLR2 or NOD2 by siRNA and examine whether 
this will affect MDP-induced IL-8 synthesis. To address the second question, we will treat the 
MDCK cells with inhibitors that are specific for ERK, p38 and JNK and then examine the IL-8 
synthesis.  
3.1.3.2. Protocol: 
 
Studies on the synergistic effect between Nod2 and TLR2 pathway:  To investigate if 
TLR2 interacts with NOD2, we try to see if TLR2 signaling upregulates Nod2 expression in 
MDCK cells: a) We stimulate MDCK cells with TLR2 specific agonists Pam3Cys and then 
detected NOD2 using Western blot and RT-PCR in MDCK cells. RNAse protection assay will 
be used to demonstrate the significant induction of IL-8 mRNA after TLR2 stimulation in 
MDCK cells in vitro. The induction of TL-8 will be demonstrated by ELISA. As we see from the 
preliminary studies, we predict that NOD2 expression will be elevated in MDCK cells; b) We 
then want to delineate the pathways that regulate NOD2 function. We will investigate the effect 
of TLR2 on NOD2-induced NF- B activation. HEK293T cells will be transfected with pcDNA-
NOD2 (3 ng) with reporter constructs RSV-KB-Luc and RSV- -galactosidase plus the dominant 
negative form of TLR2. TLR2DN doses will be used from 0 to 150 ng. 24 hours after 
transfection, luciferase activity will be determined and normalized on the basis of -
galactosidase activity[39]; c) Further, we will try to see if NOD2 regulates MDP-induced NF- B 
activation in NOD2-expressing cells. HEK293T cells will be transfected with NOD2 and 
TLR2DN, and 8 h later, stimulated with MDP (100 ng/ml). The inhibition effect of TLR2DN on 
MDP-induced NF- B activation in NOD2-transfected HEK293T cells will be observed 
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 compared with the control vector; d) If TLR2 indeed regulates NOD2-mediated NF-κB 
activation, we will further investigate the possibility that TLR2 interacts with NOD2. FLAG-
NOD2 and HA-TLR2 will be coexpressed in HEK293T cells and immunoprecipitated with anti-
HA antibody. Subsequently, we will resolve immune complexes by SDS-PAGE. Then, we will 
do the Western blot analysis with an anti-FLAG antibody to show if the TLR2-precipitated 
complexes contain NOD2.  
Studies on the role of MAP kinase pathway on the cross talk between NOD2 and TLR2:  
MAPKs can also play an important role in regulating proinflammatory gene expression other 
than NF-κB. To determine whether MAP kinase is involved in Nod2 function, we generate 
MDCK cells that stably express Nod2 or TLR2 and compare their p38 activation to the control 
MDCK cells that have been transformed with the antibiotic resistance gene only. We will then 
seek to use Nod2DN or TLR2DN constructs to investigate whether functional Nod2/TLR2 
signaling is necessary for S. aureus-induced p38 MAPK activation. Both control MDCK cells 
and MDCK cells stably transfected with Nod2 will be stimulated with S. aureus for the indicated 
time and lysed, and p38 MAPK activation will be measured via immunoblotting. Induced 
p38MAP kinase phosphorylation in the MDCK cells will be assayed by performing Western 
blotting using the phospho-p38 MAP kinase antibody. Parallel blots will be done using the 
antibody recognizing total p38 MAP kinase[42]. Total cell lysates will also be blotted with a 
phosphospecific antibody (Ab) for ERK and JNK. To verify the amount of loaded protein, the 
lysates will be also probed with anti-ERK1/2.  
JNK activity will be analyzed by a quantitative JNK kinase assay[43, 44]. Briefly, 
MDCK cells will be transfected with 500 ng of Flag-JNK1 expression vector plus 2 µg of empty 
vector, siRNA for TLR2 or NOD2 or control RNA. Forty eight hours post-transfection, we will 
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 infect cells with S. aureus for 20 min. Flag-JNK1 will be immunoprecipitated using antibodies to 
the Flag epitope. JNK1 activity of the immunoprecipitates will be determined by dividing the 
level of c-Jun phosphorylation by the amount of overexpressed Flag-JNK1 levels for each 
sample as described [44]. The level of c-Jun phosphorylation and Flag-JNK1 expression will be 
determined. 
To see if p38 regulates IL-8 expression via a posttranscriptional mechanism, we will 
consider the consequences of MAPK activation on the epithelial expression of the 
proinflammatory chemokine IL-8. We will stimulate cells with S. aureus or TNF  in the 
presence of the indicated concentration of p38 inhibitor SB-203580(2–20 M), ERK inhibitor 
(U-0126) or JNK inhibitor (JNK Inhibitor 1) (0.01% DMSO). At 5 h after the stimulation, we 
will remove the media for IL-8 assay via ELISA.  
NOD2/TLR2 siRNA experiment: The siRNA design will refer to the method mentioned 
before. In three separate experiments, TLR2 and NOD2 will be silenced by siRNA separately or 
at the same time. Two days later, we will infect cells with Gram-positive bacterium S. aureus 
and compare the IL-8 levels. To further confirm the results, reinstatement assay will be done as 
mentioned. We will redirect the NOD2 or TLR2 gene into the above cells already being treated 
with siRNA to see if the functional synthesis of IL-8 will be restored.   
To see whether S. aureus will induce a NOD2/TLR2-dependent transcription of the gene 
for IL-8, two different assays will be tested: a) reverse transcription-PCR of IL-8 mRNA in 
MDCK cells stably transfected with TLR2 and/or NOD2 siRNA; b) transactivation of an IL-8 
promoter-CAT construct in MDCK cells transiently transfected with pIL8(wt)CAT and with 
plasmids expressing NOD2 and TLR2.  
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 3.1.3.3. Expected Results, Problems, and Solutions: 
 
Based on the different characters of NOD2/TLR2 sensing, we expect that Gram-positive 
bacterial sensing specificities and functions between TLR2 and NOD2 are distinct and non-
overlapping. There exists a synergetic effect between them. We will observe TLR2DN will exert 
its effect in a dose-dependent manner to inhibit NOD2-induced NF-κB activation. Cells will be 
stimulated by either inactivated or alive Gram-positive bacterial S. aureus and we will observe 
that TLR2DN will exert its effect in a dose-dependent manner to inhibit NOD2-induced NF-κB 
activation. Further direction could determine the role of NOD2/TLR2 in innate immunity in vivo. 
Alternatively, overexpression of TLR2 and NOD2 could be done to observe the synergistic effect 
of NOD2/TLR2. Considering the expression model of NOD2, low level expressions in quiescent 
state but up-regulated after proinflammatory stimulation in epithelial cells, we would like to 
check the dichotomous role of NOD2. The upregulation of NOD2 in epithelial cells has two 
implications: initiate innate immunity against pathogen invasion or inhibit abnormal 
inflammation at the certain circumstance. To observe the inflammatory regulation mechanism, 
we utilize both a polarized model of intestinal epithelia expressing endogenous TLR2 as well as 
MDCK cells engineered to express TLR2, allowing both physiologic and mechanistic 
assessments of this signaling pathway. Cells may be directly stimulated with TNFα. Twenty four 
hours later, we will remove TNFα and treat the cells with Gram-positive bacterial, and compare 
the IL-8 level. In the parallel experiment, NOD2 will be up-regulated by TNFα first, after 24 h, 
we will treat cells with Gram-positive bacterial without depleting TNFα, and compare the IL-8 
level among different groups. 
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 3.2. Experimental details 
3.2.1. Cell culture: 
 
The Madin–Darby canine kidney (MDCK) cell lines will be cultured in Eagle's minimum 
essential medium containing 10% FBS and maintained at 37 °C in a humidified atmosphere with 
5% CO2. Polarized monolayers will be generated from cells cultured in complete medium in 12-
mm and 24-mm Transwell® filter chambers (0.4 µm pore size). The medium will be changed 
every 2 days and cell monolayers will be considered polarized when the trans-epithelial electrical 
resistance is ≥ 200 Ω cm2 as measured with the Epithelial Volt Ohmmeter [45]. 
3.2.2. Bacteria and infection: 
 
S. aureus 834 strain will be prepared as described [46]. In brief, bacteria will be cultured 
on trypticase soy agar, inoculated with trypticase soy broth, and incubated for 15 h at 37°C. The 
bacteria will be collected and resuspended by PBS. The concentration of resuspended cells will 
be adjusted spectrophotometrically at 550 nm. S. aureus suspension (1 x 109 CFU/ml in PBS) 
will be boiled for 30 min and used as heat-killed S. aureus.  
siRNA: Transfections for targeting endogenous TLR2, NOD1, NOD2 will be carried out 
using oligofectamine and dsRNA (final concentration, 200 nM) for 24 h at 37°C. The sequences 
of target mRNAs will be used in this study are TLR2, 5'-AATCCGGAGGCTGCATATTCC-3'; 
NOD1, 5'-AAGA GCCTCTTTGTCTTCACC-3'; and NOD2, 5'-AAGACATCTTCC 
AGTTACTCC-3'[47].  
3.2.3. NF- B Activation Assays: 
 
Cells will be cotransfected with RSV-KBLuc (100 ng), a reporter construct encoding the 
luciferase reporter gene B-luc under the control of a minimal promoter with an NF- B-binding 
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 site; RSV- -galactosidase (50 ng), an expression construct containing -galactosidase; and an 
indicated amount of each expression construct, by FuGENE 6, in triplicate. Cell lysates will be 
prepared 24-36 h after transfection, and the relative luciferase activity will be determined 
according to the manufacturer's instructions (Promega). Results will be normalized for 
transfection efficiency on the basis of -galactosidase activity[39]. 
RNAse protection assay: RNAse protection assay will be used to measure the pro-
inflammatory chemokines IL-8 induction on mRNA level following Tlr2 stimulation. In short, 
32P UTP radioactive labeled RNA probes will be generated using manufacturers' hCK-2 or hCK-
5 cDNA multi-templates including 15 cytokines and chemokines and 6 house keeping genes and 
T7 RNA polymerase. Radioactive probes will be used to hybridize 2 µg total RNA from cultured 
cells. Protected RNA fragments will be quantified after film exposure using Quantity One 
software [48]. 
3.2.4. MAPK assessments: 
 
Cells will be stimulated and rinsed in cold HBSS, lysed (in PBS with 1% Triton X-100, 1 
mM EDTA, 1 mM NaVO4,1mM NaF) cleared by centrifugation (10 min at 5,000 g at 4°C), and 
assayed for phospho-p38, phospho-ERK, or total P38 by SDS-PAGE immunoblotting. 
Densitometry will be performed via scanning with Scion Image densitometry software [49].  
3.2.5. Statistical analysis: 
 
For statistical analysis, ELISA samples with IL-8 levels will be performed in triplicate. 
Results will be expressed as means and standard deviations. Statistical significance will be 
determined using a one-way analysis of variance with Dunnett's post test. Differences will be 
considered significant if P values are <0.05.  
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